Revisiting the Politics of Painkillers
Despite the collateral damage, Big Pharma seems determined to preserve the market for its products, through sophisticated lobbying.
Read More
Author: C. Scott McMillin
Pharmaceutical “Cures”
From a patient’s viewpoint, physicians can be somewhat blase’ about risks associated with a medication.
Read More
In the News: Kaos Around Kratom
It may be that kratom is a drug that some can use without much difficulty, while for others, it becomes pathological.
Read More
Three Challenges
Like a stroke patient who suddenly finds himself needing to relearn basic skills that were once automatic, it may require a level of personal commitment unseen for many years.
Read More
Treatment Plan Redux
Addiction programs, conversely, targeted elimination or at least substantial reduction in substance use– a narrower goal that permitted greater focus in treatment.
Read More